Transforming India’s approach to cancer care
In India, a country with a vast population and a diverse socio-economic fabric, healthcare remains fraught with challenges including disparities in access. These socio-economic disparities are deep, and
In India, a country with a vast population and a diverse socio-economic fabric, healthcare remains fraught with challenges including disparities in access. These socio-economic disparities are deep, and
At least four million Americans under age 65 are exposed to high doses of radiation each year from medical imaging tests, according to a new study in The New England Journal of Medicine. About 400,000 of those patients receive very high doses, more than the maximum annual exposure allowed for nuclear power plant employees or anyone else who works with radioactive material.
An international web site giving information about Kandy to tourists had this to say in its concluding paragraph "the city is ugly and its air pollution unbearable". This is a serious matter since tourism in Kandy is affected by such adverse comments and furthermore, this situation greatly endangers the health of the citizens of Kandy, especially school children.
Signs memo with atomic centre Concerned at the number of cancer cases reported from south west Punjab the Guru Nanak Dev University will monitor natural uranium in water proving detrimental to health of people.
Delhi HC Ruling Big Victory For Indian Drugmakers IN A major win for Indian pharma companies, the Delhi High Court (HC) on Tuesday dismissed German drug major Bayer Healthcare
The vitamin sabotages cancer cells
A vaccine invented 40 years ago by Baruch Blumberg has prevented millions of deaths from hepatitis B and liver cancer.
Jalandhar: The Punjab government has been urged to set up a commission to find out the cancer-causing agents in the Malwa region where many persons have died due to this disease.
Virotherapy now works A cancer treatment method, called virotherapy, involves reprogramming viruses to attack cancer cells in the body. But this method wasn
To Challenge Intellectual Property Appellate Board Verdict Rejecting Its Patent Plea For Cancer Drug Nina Mehta MUMBAI THE Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said its cancer drug Glivec was not patentable.